Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of PF-05280586 versus rituximab in rheumatoid arthritis
2012-003223-38Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in rheumatoid arthritis (RA), sponsored by Pfizer. Started Feb 2013; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-003223-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003223-38.